Media & Advertising
Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
Have an interest in this Story?
Sign Up for Real-Time email updates
August 01, 2013
/PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the three and six months ended June 30, ...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Most Read Biotech Articles
Obama calls world leaders about Ukraine
President Barack Obama to Introduce Series Premiere of Cosmos!
- Eclipse Magazine
President Obama to expand coastal protection in California
- Los Angeles Times
Long-time Obama aide to leave White House
- Brisbane Courier-Mail
Governor faces fracking protesters at Democratic meeting
- San Francisco Chronicle
Senior Vice President
Sylvia M. Romagosa, MBA
Licensed Real Estate Broker
Real Estate Industry
View more profiles
Access dozens of premium and subscriptions sites
Build a News Circle
Get News Briefings
Congoo News Home
Get the Netpass
Copyright ©2014 Congoo.com. All Rights Reserved.